RF
AXSM icon

Rossby Financial’s Axsome Therapeutics AXSM Stock Holding History

Rossby Financial’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.95K Buy
+23
New +$3.97K ﹤0.01% 1579

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Rossby Financial's AXSM Position: Q1 2026 in Review

Rossby Financial opened a new position in Axsome Therapeutics (AXSM) in Q1 2026: 23 shares worth $3.95K. The stake represents ﹤0.01% of the portfolio and ranks #1579 among its holdings.

409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • Rossby Financial held 23 shares of Axsome Therapeutics worth $3.95K as of Q1 2026.
  • Axsome Therapeutics was a new Rossby Financial position in Q1 2026.
  • Axsome Therapeutics made up ﹤0.01% of Rossby Financial's portfolio in Q1 2026, its #1579 holding.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Rossby Financial's 13F filing for Q1 2026, filed 11 May 2026.